Last reviewed · How we verify

NCT04017637

Resistance Training Intervention to Promote Lean Mass in Youth With IBD

Withdrawn NA Last updated 2 June 2020
What this trial tests

NA trial testing Resistance Training in Inflammatory Bowel Disease. Withdrawn.

Timeline
6 March 2020
Primary endpoint
6 March 2020
6 March 2020

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Start date6 March 2020
Primary completion6 March 2020
Estimated completion6 March 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

Adults 14 to 18, any sex, with Inflammatory Bowel Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate feasibility, safety, and preliminary estimates of resistance training (RT) efficacy to promote lean body mass accrual in patients with CD aged 14-18. This will be achieved by conducting a parallel 2-arm randomized-controlled pilot trial of RT compared to usual care. At weeks 0 (pre-treatment), 6 (mid-treatment), and 12 (post- treatment), feedback regarding safety, feasibility, and acceptability will be collected from participants through surveys and interviews. Magnitude of the effect size of the intervention on LBM, muscle strength, and health-related quality of life (HRQoL) will also be estimated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Resistance Training

Trials testing the same drug.

Other recruiting trials for Inflammatory Bowel Disease

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04017637.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing